Table 3. Association risk SNPs in previous study and current study.
European cohort7 | British, Australia cohort8 | Han Chinese cohort9 | Current study | |||||
SNP | Minor allele | Allele frequencya | Allele frequencya | Allele frequencya | Allele frequencya | OR (95% CI)b | P-valueb | HWEc |
rs3734523 | A | 0.09/0.12 | 0.02/0.04 | 0.58 (0.33–1.00) | 0.052 | 0.265 | ||
rs4672495 | G | 0.36/0.32 | 0.17/0.19 | 0.89 (0.67–1.17) | 0.400 | 0.632 | ||
rs10865331 | A | 0.43/0.36 | 0.45/0.37 | 0.54/0.48 | 0.53/0.47 | 1.65 (1.21–2.23) | 0.001 ** | 0.817 |
rs11209032 | G | 0.36/0.33 | 0.49/0.49 | 1.04 (0.26–1.96) | 0.794 | 0.073 | ||
rs27434 | G | 0.26/0.21 | 0.55/0.53 | 0.46/0.50 | 0.86 (0.94–1.96) | 0.347 | 0.336 | |
rs13210693 | G | 0.47/0.44 | 0.52/0.48 | 1.38 (1.96–2.06) | 0.039 | 0.867 |
χ2-test was applied for testing genotype frequencies of SNPs in controls and patients with AS.
**Significant (p<0.0017) value is in bold.
Allele frequency in case/control.
The OR and P-value were showed for dominant model of SNPs.
HWE were performed by chi-square.
The reference numbers are as the same as that in the text.